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Abstract 
Background. Limited evidence suggests that pulmonary rehabilitation be included in the 
management of restrictive lung diseases. The purpose of this study was to document pulmonary 
rehabilitation outcomes in patients with respiratory diseases other than chronic obstructive 
pulmonary disease (COPD). 
Methods. Clinical outcomes of 31patients with respiratory diseases other than COPD and 190 
patients with COPD, seen over a 35-month period, were reviewed retrospectively. Patients were 
evaluated for a 6-minute walk, arm curl strength, chair stand strength, the St. George’s 
Respiratory Questionnaire (SGRQ) total score, SGRQ symptom scores, SGRQ activity levels, 
and SGRQ impact of respiratory illness on the patient’s life. Outcome measures were obtained 
before the start of pulmonary rehabilitation and after a minimum of nine therapy visits.  
Results. Pre- and post-rehabilitation changes in the 6-minute walk, arm curl strength, chair stand 
strength, the St. George’s Respiratory Questionnaire (SGRQ) total score, SGRQ symptom 
scores, SGRQ activity levels, and SGRQ impact scores improved significantly for both groups.  
However, non-COPD patients achieved significantly higher mean SGRQ impact scores and arm 
curl strength than patients with COPD.  
Conclusions.  Pulmonary rehabilitation should be recommended for all patients with respiratory 
disease, not only those with COPD.  
KS J Med 2014; 7(1):6-10. 
 
 
Introduction 
Many patients with obstructive lung 
diseases have activity limitations and 
deconditioning as a result of their poor lung 
function and dyspnea.
1
 In 2000, the 
American Thoracic Society issued a 
consensus statement supporting pulmonary 
rehabilitation in idiopathic pulmonary 
fibrosis (IPF) patients.
2
 In 2007, the 
American College of Chest Physicians and 
the American Association of Cardiovascular 
and Pulmonary Rehabilitation published a 
Grade 1 B evidence of recommendation for 
pulmonary rehabilitation (PR) in patients 
with chronic lung diseases other than 
COPD.
2
  
Further study is needed to understand the 
benefits of PR in non-COPD patients.  
Limited evidence suggests that PR should be 
added within the management algorithm of 
restrictive lung diseases to reduce morbidity 
and lower the cost burden. The purpose of 
this study was to document the outcomes of 
PR in patients with respiratory diseases 
other than COPD and compare them to those 
with COPD. 
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Methods
A retrospective review of PR outcomes 
was conducted in patients with respiratory 
disease other than COPD who were enrolled 
in a hospital-based pulmonary rehabilitation 
program between January 2009 and 
November 2011. These outcomes were 
compared to patients with COPD seen in the 
same program over the study period. 
Subjects completed a minimum of nine 
therapy sessions and were between the ages 
of 18 to 75. Exclusion criteria included 
recent myocardial infarction, decompensated 
heart failure, terminal cancer, disabling 
cardiovascular accidents, dementia, 
alcoholism, pregnancy, prisoners, and age 
less than 18 or greater than 75. 
An order from a licensed physician was 
required for evaluation and treatment. Each 
subject had an initial evaluation visit 
performed by a respiratory therapist or 
registered nurse to verify the patient was an 
appropriate candidate for pulmonary 
rehabilitation. Baseline outcome measures 
were obtained at that visit.  
The 6-minute walk evaluation was 
completed according to American Thoracic 
Society Guidelines.
3
 An arm curl test was 
performed using a bicep curl movement with 
a hand weight. Men used an 8-pound 
weight; women used a 5-pound weight. The 
maximum number of full bicep curls 
completed in 30 seconds was recorded. The 
chair stand test was performed using a 
designated chair. Patients were instructed to 
rise from seated position to a full stand 
position, without using arm swing or push 
for assistance and maximum number of sit 
to stand movements in 30 seconds were 
recorded.     
The patient’s quality of life was assessed 
using the St. George’s Respiratory 
Questionnaire (SGRQ). It is a 16-item 
questionnaire measuring health impairment 
in patients with lung disease. The 
questionnaire assessed patients’ 1-month 
recall of respiratory symptoms, activity 
disturbance, and impact of respiratory status 
on their lives. 
Data from these variables as well as 
history and physical exam were used to 
create an individualized treatment plan for 
approval by the patient’s referring physician 
and the PR medical director. After the initial 
evaluation, patients returned for twice 
weekly visits for breathing retraining, 
education to improve self-management of 
lung disease, exercise training, and social 
support. After finishing a minimum nine 
sessions of pulmonary rehabilitation, 
measurements were repeated to compare 
with the baseline. The comparison of patient 
variables before and after the program 
provided the data for this study.   
This study was approved by the 
institutional review boards at Via Christi 
Health and the University of Kansas School 
of Medicine-Wichita.   
Data were analyzed between groups for 
each outcome variable using an analysis of 
variance for independent samples. Data were 
analyzed within groups for each outcome 
variable using a repeated measures Student 
t.  Demographics were analyzed by Student t 
tests. 
 
Results 
Thirty-one patients with respiratory 
disease other than COPD and 190 patients 
with COPD met study criteria. Diagnoses in 
the non-COPD group included bronchi-
ectasis (n = 1), pulmonary fibrosis (n = 6), 
interstitial lung disease (ILD; n = 8), 
pulmonary hypertension (n = 6), sarcoidosis 
(n = 5), asthma (n = 2), cystic fibrosis (n = 
1), lung cancer (n = 1), and Wegner’s 
granulo-matosis (n = 1). Mean age in the 
non-COPD group was 63 years and was 
significantly younger than the 70 years in 
the COPD group (p < 0.001). 
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Non-COPD and COPD groups 
independently showed significant 
improvement with rehabilitation on all 
outcomes measures (Tables 1 and 2). The 
non-COPD group revealed better combined 
SGRQ impact scores (45.1 vs 36.8; p < 
0.001) and arm curl strength scores (17.6 vs 
14.2; p < 0.001) than the COPD group. No 
other group differences were observed. 
 
 
Table 1. Mean pre- and post-pulmonary rehabilitation assessments in patients with non-COPD 
diagnosis. 
Tests  Pre-Rehabilitation Post-Rehabilitation p value 
SGRQ total score 58 50 < 0.05 
SGRQ symptom score 53 45 < 0.01 
SGRQ impact score 48 40 < 0.05 
SGRQ activity score  76 68 < 0.01 
6-minute walk 245 285 < 0.01 
Chair stand strength 8 9 < 0.05 
Arm curl strength  16 19 < 0.001 
 
Table 2. Mean pre- and post-pulmonary rehabilitation assessments in patients with COPD. 
 
Discussion 
Pulmonary rehabilitation improved all 
measured outcomes in both groups of 
patients. PR was beneficial to patients with 
all types of respiratory disease, not only 
those with COPD. The younger group of 
non-COPD patients showed higher SGRQ 
impact scores and arm curl strength. These 
differences may be related to age or severity 
of disease. No group differences, however, 
were seen in any other outcome measures. 
PR aids in improving a patient’s 
functional status and controlling their 
symptoms, especially dyspnea (Grade 1A 
evidence) and fatigue.
4
 PR enlightens 
patients about their disease treatment 
options and improves their physical 
Tests  Pre-Rehabilitation Post-Rehabilitation p-value 
SGRQ total score 54 44 < 0.0001 
SGRQ symptom score 58 46 < 0.0001 
SGRQ impact score  43 30 < 0.0001 
SGRQ activity score  73 65 < 0.0001 
6-minute walk  265 311 < 0.0001 
Chair stand strength 7 9 < 0.0001 
Arm curl strength  12 16 < 0.0001 
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capabilities and capacities. Low self-esteem 
and quality of life usually is present 
secondary to physical disability thus 
worsening the patient’s main symptom, 
shortness of breath. Anxiety also worsens 
dyspnea. On the other hand, depression, 
anxiety, and dyspnea worsens the underlying 
physical impairment.
5
 PR does not reverse 
the disease but reduces symptoms, 
disability, and mortality, resulting in a 
decrease in hospital stay and reduction in 
hospital admissions, thus lowering the cost 
burden on health care system.
4
  
PR consists of patient assessment, 
exercise, dietary recommendations, and 
psychosocial support.
4
 Training of muscles 
of ambulation must be implemented within 
the program (Grade 1 A recommendation). 
Benefits are observed over 6 to 12 weeks, 
with longer programs producing more 
benefits.
3
 Effects may last up to 18 months 
in COPD patients;
6
 no data are known for 
patients with other respiratory diseases. 
Rehabilitation programs have been well 
developed for patients suffering from 
advanced COPD. It also has been used in 
non-COPD patients, mainly with interstitial 
lung diseases, cystic fibrosis, bronchiectasis, 
and thoracic cage abnormalities.
4
 No clinical 
recommendation is available with regards to 
PR in diseases other than COPD. All of the 
evidence for non-COPD programs was 
based on expert opinion. Treatment for these 
patients should be individualized.
7
  
Growing evidence supports the need for 
PR in patients with Idiopathic Pulmonary 
Fibrosis (IPF).
7,8
 PR in restrictive lung 
diseases has shown promising results.
8
 
Foster and Thomas evaluated 32 patients 
with ILD, bronchiectasis, fibrothorax, 
thoracoplasty, and neuromuscular abnorm-
alities and they concluded that the degree of 
benefit was equivalent to COPD patients.
9
  
PR improves activity and health-related 
quality of life in patients with idiopathic 
pulmonary fibrosis.
10
 Further research is 
required to assess the optimal timing of PR 
and if there is a difference in benefit within 
subgroup of diseases.
11 
Limitation of the data exist with 
restrictive lung disease, and that is because 
of the heterogeneity of the pathophysiology 
of the diseases, thus leading to different 
mechanisms for exercise limitations.
2
 Our 
study showed that PR may be beneficial not 
only in patients with COPD, ILD, and IPF, 
but also in other pulmonary diseases. 
Further disease specific studies should 
establish standard protocols and guidelines 
for referral to PR in non-COPD diagnosis. 
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